Followers

December 16, 2023

US FDA approves Astellas' combination therapy for bladder cancer

The U.S. Food and Drug Administration on Friday approved Astellas Pharma's Padcev in combination with Merck's Keytruda for a type of bladder cancer.


No comments:

Post a Comment